Regeneron Pharmaceuticals (REGN) stock — price, news and analysis
Regeneron Pharmaceuticals (REGN) trades on US markets (NASDAQ / NYSE). OneDayTrading is tracking 3 recent stories on REGN — 3 bullish and 0 bearish — alongside its live price and interactive chart below.
Catalystsby D-day
FOMC = U.S. Fed official schedule · expiry = US options/futures (3rd Friday)
Latest REGN news
Eli Lilly, Regeneron Among First Seven in FDA's Manufacturing PreCheck Pilot — the Supply Chain Acceleration Markets Are Underpricing
Jun 30, 2026
Parabilis IPO Pops Bigger Than SpaceX as Regeneron (REGN) Backs the Biotech
Jun 28, 2026
AbbVie (ABBV) Eyes $10.9B Biotech Buyout to Add Eczema Drug, Pressuring Dupixent
Jun 21, 2026Related stocks
Tickers frequently mentioned alongside REGN in recent news.
REGN — frequently asked
What is the REGN stock price today?
The live Regeneron Pharmaceuticals (REGN) price and an interactive chart are shown at the top of this page, updated in real time during US market hours (9:30 AM – 4:00 PM ET) and at the last close otherwise.
Where is REGN listed?
Regeneron Pharmaceuticals (REGN) is a US-listed equity traded on the NASDAQ / NYSE. It belongs to the 바이오 sector.
Is the latest REGN news bullish or bearish?
Of the 3 recent REGN stories we track, 3 are bullish, 0 bearish and 0 neutral. See the news section below for details.
Prices are delayed outside US market hours and provided for information only — not investment advice. Regeneron Pharmaceuticals (REGN) news is produced from public information.